Purification and Loading of CD1a Glycoprotein
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Boston Children's Hospital, Harvard University, Australian Regenerative Medicine Institute, Monash University, Kyoto University
Variable analysis
- Endoglycosidase H treatment
- Incubation of CD1a with GD3 at a molar ratio of 1:15
- Incubation of GD3-CD1a with urushiol C15:2 at a molar ratio of 1:15
- Purified CD1a loaded with GD3
- GD3 displacement by urushiol C15:2
- Mammalian expression system for CD1a production
- Purification of CD1a as previously described
- Using a solution containing 0.5% tyloxapol and 10 mM Tris buffer at pH 8.0 to dissolve GD3 and urushiol C15:2
- Performing ion exchange chromatography (MonoQ 10/100 GL) to purify the samples
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!